Current Studies of Osteoclastogenesis and Potential Drug Targets

Author(s): Lingbo Kong

Journal Name: Current Drug Targets

Volume 21 , Issue 4 , 2020

Become EABM
Become Reviewer

[1]
Biao Wang, Wenjie Gao, Dingjun Hao. Current study of the detection and treatment targets of spinal tuberculosis. Current Drug Targets 2020; 21: 320-7.
[2]
Lingbo Kong, Xiaobin Yang. Study of intercellular adhesion molecule-1 (ICAM-1) on bone homeostasis. Curr Drug Targets 2020; 21: 328-37.
[3]
Yuan Liu, Yang Cao, Wanli Smith, Baorong He, Liang Yan. Current study of monocytes/macrophages stimuli for inflammatory bone diseases. Current Drug Targets 2020; 21: 338-43.
[4]
Chang Liu, Yuan He, Xiaobing Xu, Lijun He, Baorong He, Lingbo Kong. The study of natural compounds targeting RANKL signaling pathway for the treatment of bone diseases. Current Drug Targets 2020; 21: 344-57.
[5]
Jun Wang, Haishi Zheng, Rui Ma. Natural occurring compounds inhibit osteoclastogenesis via NFATc1-related signaling pathways. Current Drug Targets 2020; 21: 358-64.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 4
Year: 2020
Page: [319 - 319]
Pages: 1
DOI: 10.2174/138945012104200129122651

Article Metrics

PDF: 19
HTML: 3